ライフサイエンスコーパス: type I diabetes mellitus

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 tion (IIT) in the treatment of patients with type I diabetes mellitus.

2 ntigens targeted by self-reactive T cells in type I diabetes mellitus.

3 te to diabetic nephropathy susceptibility in type I diabetes mellitus.

4 tion is becoming an accepted therapy to cure type I diabetes mellitus.

5 ed treatment option for select patients with type I diabetes mellitus.

6 nery and as major targets of autoimmunity in type I diabetes mellitus.

7 an attractive alternative for patients with type I diabetes mellitus.

8 gerhans to human patients in efforts to cure type I diabetes mellitus.

9 e thyroid disease, rheumatoid arthritis, and type I diabetes mellitus.

10 ation and arise spontaneously in autoimmune (type I) diabetes mellitus.

11 ion and disease course of insulin-dependent (type I) diabetes mellitus.

12 we describe our experience with two cases of type I diabetes mellitus and glycogen hepatopathy.

13 IDDM8, a linkage and association signal for type I diabetes mellitus and rheumatoid arthritis.

14 Two thirds of the patients had type I diabetes mellitus, and approximately 50% were men

15 arthritis, Sjogren syndrome, celiac disease, type I diabetes mellitus, and systemic lupus erythematos

16 lupus erythematosus, multiple sclerosis, and type I diabetes mellitus, as indicated by the efficacy o

17 for association with diabetic nephropathy in type I diabetes mellitus, by using both case-control and

18 in a streptozocin (STZ)-induced rat model of type I diabetes mellitus (DM) and to understand the path

19 of insulin-secreting beta-cells that causes type I diabetes mellitus (DM) occurs in part by apoptosi

20 r patient survival was 36%, 49%, and 65% for type I diabetes mellitus (DM), type II DM, and nondiabet

21 Type I diabetes mellitus (IDDM) is a T cell-dependent au

22 pment in rodent models of insulin-dependent (type I) diabetes mellitus (IDDM).

23 ning porcine islets as long-term therapy for type I diabetes mellitus in Biobreeding/Worcester (BB/Wo

24 mechanism by which TNF and anti-TNF modulate type I diabetes mellitus in NOD mice.

25 During the development of type I diabetes mellitus in nonobese diabetic (NOD) mice

26 factor-alpha (TNF) differentially modulates type I diabetes mellitus in the nonobese diabetic (NOD)

27 Type I diabetes mellitus is an autoimmune disease charac

28 Poorly controlled or untreated type I diabetes mellitus is characterized by hyperglycem

29 In type I diabetes mellitus, islet transplantation provides

30 months) and 108 patients in five studies of type I diabetes mellitus (mean length of follow-up, 9 to

31 PIT in severely insulinopenic type I diabetes mellitus primates resulted in restoratio

32 The SUMO-4M (Met) variant is associated with type I diabetes mellitus susceptibility in families (p =

33 ecause LBH gene variants are associated with type I diabetes mellitus, systemic lupus erythematosus,

34 c T cells prevented the adoptive transfer of type I diabetes mellitus (T1DM) to NOD/scid mice.

35 ials of multiple sclerosis (alemtuzumab) and type I diabetes mellitus (teplizumab, otelixizumab).

36 Type I diabetes mellitus (TIDM) is an autoimmune disorde

37 results offer an exciting new potential for type I diabetes mellitus treatment.

38 Type I diabetes mellitus was induced in male rats by all

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。